Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells

Ann R Finch, Lisa Green, James N Hislop, Eamonn Kelly, Craig A McArdle

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

GnRH receptors (GnRH-Rs) mediate direct antiproliferative effects on hormone-dependent cancer cells. GnRH-Rs can be grouped according to ligand specificity (for GnRH-I and -II), and there is evidence that type II GnRH ligands and/or receptors can inhibit proliferation. Type I GnRH-Rs (e.g. human and sheep) lack the C-terminal tails found in other G protein-coupled receptors including type II GnRH-Rs (e.g. Xenopus; XGnRH-R). This underlies the remarkable resistance of type I GnRH-Rs to desensitization and may be important for chronic effects on proliferation. To test this, we have compared the antiproliferative effects of GnRH-Rs expressed in MCF7 breast cancer cells using recombinant adenovirus (Ad). Endogenous GnRH-Rs were not detected, but infection with Ad-expressing sheep GnRH-Rs (sGnRH-R) facilitated proliferation inhibition by Buserelin, and maximum inhibition required only 10,000-20,000 sGnRH-Rs. XGnRH-Rs were much less efficient at inhibiting proliferation and were internalized faster than sGnRH-Rs. Thus, the type II GnRH-R is less efficient at inhibiting proliferation, presumably because it is rapidly desensitized and/or internalized. Moreover, comparisons of human GnRH-R, sGnRH-R, and XGnRH-R, as well as chimeric receptors (type I GnRH-Rs with C-terminal tails from XGnRH-Rs), revealed that C-terminal tail addition increases receptor expression and thereby increases the efficiency with which the vector facilitates the antiproliferative effect.
Original languageEnglish
Pages (from-to)1823-32
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number4
DOIs
Publication statusPublished - Apr 2004

Fingerprint

LHRH Receptors
Cells
Breast Neoplasms
Tail
Gonadotropin-Releasing Hormone
Sheep
Buserelin
Ligands
Adenoviridae Infections
G-Protein-Coupled Receptors
Xenopus
Adenoviridae
Hormones

Keywords

  • Animals
  • Antineoplastic Agents, Hormonal
  • Breast Neoplasms
  • Buserelin
  • Cell Division
  • Cell Line, Tumor
  • Chimera
  • Female
  • Gene Transfer Techniques
  • Humans
  • Molecular Conformation
  • Peptide Fragments
  • Receptors, LHRH
  • Sheep
  • Signal Transduction
  • Species Specificity
  • Xenopus laevis

Cite this

Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells. / Finch, Ann R; Green, Lisa; Hislop, James N; Kelly, Eamonn; McArdle, Craig A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 4, 04.2004, p. 1823-32.

Research output: Contribution to journalArticle

@article{7425537de92c48a5bb2d38334432c76f,
title = "Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells",
abstract = "GnRH receptors (GnRH-Rs) mediate direct antiproliferative effects on hormone-dependent cancer cells. GnRH-Rs can be grouped according to ligand specificity (for GnRH-I and -II), and there is evidence that type II GnRH ligands and/or receptors can inhibit proliferation. Type I GnRH-Rs (e.g. human and sheep) lack the C-terminal tails found in other G protein-coupled receptors including type II GnRH-Rs (e.g. Xenopus; XGnRH-R). This underlies the remarkable resistance of type I GnRH-Rs to desensitization and may be important for chronic effects on proliferation. To test this, we have compared the antiproliferative effects of GnRH-Rs expressed in MCF7 breast cancer cells using recombinant adenovirus (Ad). Endogenous GnRH-Rs were not detected, but infection with Ad-expressing sheep GnRH-Rs (sGnRH-R) facilitated proliferation inhibition by Buserelin, and maximum inhibition required only 10,000-20,000 sGnRH-Rs. XGnRH-Rs were much less efficient at inhibiting proliferation and were internalized faster than sGnRH-Rs. Thus, the type II GnRH-R is less efficient at inhibiting proliferation, presumably because it is rapidly desensitized and/or internalized. Moreover, comparisons of human GnRH-R, sGnRH-R, and XGnRH-R, as well as chimeric receptors (type I GnRH-Rs with C-terminal tails from XGnRH-Rs), revealed that C-terminal tail addition increases receptor expression and thereby increases the efficiency with which the vector facilitates the antiproliferative effect.",
keywords = "Animals, Antineoplastic Agents, Hormonal, Breast Neoplasms, Buserelin, Cell Division, Cell Line, Tumor, Chimera, Female, Gene Transfer Techniques, Humans, Molecular Conformation, Peptide Fragments, Receptors, LHRH, Sheep, Signal Transduction, Species Specificity, Xenopus laevis",
author = "Finch, {Ann R} and Lisa Green and Hislop, {James N} and Eamonn Kelly and McArdle, {Craig A}",
year = "2004",
month = "4",
doi = "10.1210/jc.2003-030787",
language = "English",
volume = "89",
pages = "1823--32",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells

AU - Finch, Ann R

AU - Green, Lisa

AU - Hislop, James N

AU - Kelly, Eamonn

AU - McArdle, Craig A

PY - 2004/4

Y1 - 2004/4

N2 - GnRH receptors (GnRH-Rs) mediate direct antiproliferative effects on hormone-dependent cancer cells. GnRH-Rs can be grouped according to ligand specificity (for GnRH-I and -II), and there is evidence that type II GnRH ligands and/or receptors can inhibit proliferation. Type I GnRH-Rs (e.g. human and sheep) lack the C-terminal tails found in other G protein-coupled receptors including type II GnRH-Rs (e.g. Xenopus; XGnRH-R). This underlies the remarkable resistance of type I GnRH-Rs to desensitization and may be important for chronic effects on proliferation. To test this, we have compared the antiproliferative effects of GnRH-Rs expressed in MCF7 breast cancer cells using recombinant adenovirus (Ad). Endogenous GnRH-Rs were not detected, but infection with Ad-expressing sheep GnRH-Rs (sGnRH-R) facilitated proliferation inhibition by Buserelin, and maximum inhibition required only 10,000-20,000 sGnRH-Rs. XGnRH-Rs were much less efficient at inhibiting proliferation and were internalized faster than sGnRH-Rs. Thus, the type II GnRH-R is less efficient at inhibiting proliferation, presumably because it is rapidly desensitized and/or internalized. Moreover, comparisons of human GnRH-R, sGnRH-R, and XGnRH-R, as well as chimeric receptors (type I GnRH-Rs with C-terminal tails from XGnRH-Rs), revealed that C-terminal tail addition increases receptor expression and thereby increases the efficiency with which the vector facilitates the antiproliferative effect.

AB - GnRH receptors (GnRH-Rs) mediate direct antiproliferative effects on hormone-dependent cancer cells. GnRH-Rs can be grouped according to ligand specificity (for GnRH-I and -II), and there is evidence that type II GnRH ligands and/or receptors can inhibit proliferation. Type I GnRH-Rs (e.g. human and sheep) lack the C-terminal tails found in other G protein-coupled receptors including type II GnRH-Rs (e.g. Xenopus; XGnRH-R). This underlies the remarkable resistance of type I GnRH-Rs to desensitization and may be important for chronic effects on proliferation. To test this, we have compared the antiproliferative effects of GnRH-Rs expressed in MCF7 breast cancer cells using recombinant adenovirus (Ad). Endogenous GnRH-Rs were not detected, but infection with Ad-expressing sheep GnRH-Rs (sGnRH-R) facilitated proliferation inhibition by Buserelin, and maximum inhibition required only 10,000-20,000 sGnRH-Rs. XGnRH-Rs were much less efficient at inhibiting proliferation and were internalized faster than sGnRH-Rs. Thus, the type II GnRH-R is less efficient at inhibiting proliferation, presumably because it is rapidly desensitized and/or internalized. Moreover, comparisons of human GnRH-R, sGnRH-R, and XGnRH-R, as well as chimeric receptors (type I GnRH-Rs with C-terminal tails from XGnRH-Rs), revealed that C-terminal tail addition increases receptor expression and thereby increases the efficiency with which the vector facilitates the antiproliferative effect.

KW - Animals

KW - Antineoplastic Agents, Hormonal

KW - Breast Neoplasms

KW - Buserelin

KW - Cell Division

KW - Cell Line, Tumor

KW - Chimera

KW - Female

KW - Gene Transfer Techniques

KW - Humans

KW - Molecular Conformation

KW - Peptide Fragments

KW - Receptors, LHRH

KW - Sheep

KW - Signal Transduction

KW - Species Specificity

KW - Xenopus laevis

U2 - 10.1210/jc.2003-030787

DO - 10.1210/jc.2003-030787

M3 - Article

VL - 89

SP - 1823

EP - 1832

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -